Merck Faces a Jury Trial.
-
Merck faces intense scrutiny as its first jury trial over the Gardasil vaccine begins, with claims it misled the public on safety and effectiveness.
The case revolves around claims that Merck overstated the benefits of the vaccine while downplaying its risks, leaving consumers and doctors in the dark. The HPV vaccine, which prevents cervical and other cancers, made Merck billions in 2023 alone—but now, it’s facing a major legal challenge.
Jurors will decide if Merck withheld side-effect reports from regulators and launched misleading marketing campaigns that misrepresented the vaccine’s true risks.
Merck insists its vaccine is safe, and has strong scientific backing.
But this trial could change everything for the future of vaccine safety and corporate responsibility, and reshape the way even more people won’t trust Pharma.
Would love to hear what you think or know about this case.
Log in to reply.